Vaccine News and Research

Latest Vaccine News and Research

Clinical severity of COVID-19 caused by SARS-CoV-2 variants and the effectiveness of mRNA vaccines against them

Clinical severity of COVID-19 caused by SARS-CoV-2 variants and the effectiveness of mRNA vaccines against them

10 Feb 2022
New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

10 Feb 2022
Properties and pharmacokinetics an oral drug candidate for COVID-19 treatment

Properties and pharmacokinetics an oral drug candidate for COVID-19 treatment

10 Feb 2022
Study explores protection against Omicron and Delta infections by COVID-19 vaccination and previous infection

Study explores protection against Omicron and Delta infections by COVID-19 vaccination and previous infection

10 Feb 2022
Rapid generation and evaluation of an mRNA vaccine candidate specific to Omicron

Rapid generation and evaluation of an mRNA vaccine candidate specific to Omicron

10 Feb 2022
Protective efficacy of BNT162b2 and Ad26.COV2.S against SARS-CoV-2 Omicron challenge in nonhuman primates

Protective efficacy of BNT162b2 and Ad26.COV2.S against SARS-CoV-2 Omicron challenge in nonhuman primates

10 Feb 2022
The effect of Omicron mutations at the fundamental atomic scale level

The effect of Omicron mutations at the fundamental atomic scale level

10 Feb 2022
Measuring T cell responses to SARS-CoV-2 vaccination and infection in healthcare workers with two different assays

Measuring T cell responses to SARS-CoV-2 vaccination and infection in healthcare workers with two different assays

10 Feb 2022
Study shows immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in Congolese populations

Study shows immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in Congolese populations

10 Feb 2022
First computational model simulates many variables affecting COVID-19 transmission

First computational model simulates many variables affecting COVID-19 transmission

10 Feb 2022
Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

9 Feb 2022
Machine learning highly effective at identifying SARS-CoV-2 variants

Machine learning highly effective at identifying SARS-CoV-2 variants

9 Feb 2022
Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

9 Feb 2022
Newborn antibodies following maternal COVID-19 vaccination persist for up to six months

Newborn antibodies following maternal COVID-19 vaccination persist for up to six months

9 Feb 2022
Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

9 Feb 2022
University of Michigan expert discusses about COVID-19 vaccine for kids under 5

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

9 Feb 2022
Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

9 Feb 2022
Study explores wastewater surveillance of US military installations to mitigate the spread of SARS-CoV-2

Study explores wastewater surveillance of US military installations to mitigate the spread of SARS-CoV-2

9 Feb 2022
Philippines starts vaccinating children aged five to 11 against COVID-19

Philippines starts vaccinating children aged five to 11 against COVID-19

9 Feb 2022
Study compares the neutralizing potential of antibodies against two Omicron variants

Study compares the neutralizing potential of antibodies against two Omicron variants

9 Feb 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback